Yes, you can check testosterone levels at any time of day when using testosterone 1.62% gel
For transdermal testosterone gels specifically, serum testosterone can be assessed at any time after the patient has been on treatment for at least 1 week, and the dose should be adjusted to achieve levels in the mid-normal range. 1
Key Monitoring Guidelines for Testosterone 1.62% Gel
Timing of Testosterone Measurement
Unlike injectable testosterone formulations that require specific timing (midway between injections) or patches (3-12 hours post-application), transdermal gels provide stable steady-state levels that eliminate the need for time-of-day restrictions once steady state is achieved.
The Endocrine Society guidelines consistently specify for transdermal gels: "assess testosterone level any time after patient has been on treatment for at least 1 wk" 2, 1. The FDA label for testosterone 1.62% gel confirms this approach 3.
When to Check Levels
- Initial monitoring: 3-6 months after starting therapy
- Dose titration: At approximately 14 days and 28 days after treatment initiation or dose adjustment 3
- Ongoing monitoring: Periodically thereafter (typically annually once stable)
Target Range
The goal is to maintain serum testosterone concentrations in the mid-normal range for healthy young men (approximately 400-700 ng/dL or 14-24 nmol/L) 1, 4.
Important Caveats
Why Gels Are Different
Transdermal gels achieve relatively stable steady-state concentrations after about 2 days of application 5. This pharmacokinetic profile differs fundamentally from:
- Injectable testosterone (requires mid-interval measurement due to peak-trough fluctuations)
- Patches (require 3-12 hour post-application timing)
- Oral testosterone undecanoate (requires 3-5 hours post-ingestion timing)
The One-Week Rule
You must wait at least 1 week after starting treatment or changing doses before checking levels 2, 1. This allows adequate time to reach steady state.
Application Site Matters for Dosing (Not Timing)
While you can check levels anytime, the application site affects bioavailability. Testosterone 1.62% gel applied to the abdomen shows 30-40% lower bioavailability compared to upper arms/shoulders 5. The FDA-approved application sites are shoulders and upper arms only 3—not the abdomen, genitals, chest, armpits, or knees.
Practical Clinical Approach
- Start therapy with 40.5 mg daily (2 pump actuations) applied to shoulders/upper arms
- First check at 14 days (any time of day)
- Adjust dose if needed based on results:
750 ng/dL: decrease by 20.25 mg
- 350-750 ng/dL: continue current dose
- <350 ng/dL: increase by 20.25 mg
- Recheck at 28 days if dose adjusted
- Monitor at 3-6 months, then annually once stable
This flexibility in timing makes testosterone gel monitoring more convenient than other formulations, though the trade-off is that single measurements may not always reflect the true 24-hour average 6. However, the guidelines prioritize practical clinical monitoring over perfect pharmacokinetic precision for gel formulations.